Chemotherapy in epithelial ovarian cancer

被引:78
|
作者
Pignata, Sandro [1 ]
Cannella, Lucia [1 ]
Leopardo, Davide [1 ]
Pisano, Carmela [1 ]
Bruni, Giovanni Salvatore [1 ]
Facchini, Gaetano [1 ]
机构
[1] Natl Canc Inst Naples, Dept Urol & Gynecol, Div Med Oncol, I-80131 Naples, Italy
关键词
Ovarian cancer; Chemotherapy; PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-III TRIAL; PACLITAXEL-RESISTANT OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; INTRAPERITONEAL CISPLATIN; INTERGROUP TRIAL; RANDOMIZED-TRIAL; INTRAVENOUS CHEMOTHERAPY; DOCETAXEL-CARBOPLATIN; 1ST-LINE TREATMENT;
D O I
10.1016/j.canlet.2011.01.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50 years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 83
页数:11
相关论文
共 50 条
  • [21] Intraperitoneal chemotherapy in older women with epithelial ovarian cancer
    O'Cearbhaill, Roisin
    Li, Daneng
    Shi, Weiji
    Thaler, Howard
    Sabbatini, Paul J.
    Konner, Jason
    Hensley, Martee L.
    Aghajanian, Carol A.
    Lichtman, Stuart M.
    Tew, William P.
    JOURNAL OF GERIATRIC ONCOLOGY, 2012, 3 (03) : 189 - 195
  • [22] Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
    Chen, Wei-Chun
    Huang, Huei-Jean
    Yang, Lan-Yan
    Pan, Yu-Bin
    Huang, Kuan-Gen
    Lin, Cheng-Tao
    Chen, Min-Yu
    Tang, Yun-Hsin
    Chang, Ting-Chang
    Lai, Chyong-Huey
    Chou, Hung-Hsueh
    BIOMEDICAL JOURNAL, 2022, 45 (05) : 821 - 827
  • [23] Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey
    Giuseppe Grosso
    Diego Rossetti
    Federico Coccolini
    Giorgio Bogani
    Luca Ansaloni
    Luigi Frigerio
    Archives of Gynecology and Obstetrics, 2014, 290 : 425 - 434
  • [24] Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey
    Grosso, Giuseppe
    Rossetti, Diego
    Coccolini, Federico
    Bogani, Giorgio
    Ansaloni, Luca
    Frigerio, Luigi
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (03) : 425 - 434
  • [25] Hyperthermic Intraperitoneal Chemotherapy as a Treatment for Epithelial Ovarian Cancer
    Fahim, Mohamed Ibrahim
    Nassar, Omaya Abdelhamid
    Mansour, Osman Mohamed
    Ali, Abdelmaksoud Mohamed
    Mahmoud, Ahmed-Mostafa
    Hafez, Nesreen Hassan
    Allam, Rasha Mahmoud
    Kamal, Amr
    Ghareeb, Mohamed
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2019, 10 (03) : 417 - 421
  • [26] Effect of progesterone combined with chemotherapy on epithelial ovarian cancer
    Chen, XJ
    Feng, YJ
    CHINESE MEDICAL JOURNAL, 2003, 116 (03) : 388 - 391
  • [27] Role of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
    du Bois, Andreas
    Baert, Thais
    Vergote, Ignace
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27) : 2398 - +
  • [28] Effect of progesterone combined with chemotherapy on epithelial ovarian cancer
    陈晓军
    丰有吉
    Chinese Medical Journal, 2003, (03)
  • [29] First-line Chemotherapy in Epithelial Ovarian Cancer
    Bookman, Michael A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2012, 55 (01): : 96 - 113
  • [30] Primary chemotherapy and maintenance therapy in epithelial ovarian cancer
    A. G. Zeimet
    D. Reimer
    N. Concin
    S. Braun
    C. Marth
    memo - Magazine of European Medical Oncology, 2008, 1 (2) : 99 - 102